Received: 29 May 2021
Accepted: 14 September 2021
First Online: 21 September 2021
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This retrospective analysis was approved by the Ethics Committee of Drug Clinical Trial in Yan'an Hospital, Kunming Medical University (IRB-PJ-2017-003). Informed consent for the use of a novel stent during treatment (Talos stent) and for the analysis of data published in the study was obtained from all the patients. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.